[1] Berkhemer OA,Fransen PS,Beumer D,et al.A randomizedtrial of intraarterial treatment for acute ischemic stroke[J].N Engl Med,2015,372(1):11~20. [2] Bracard S,Ducrocq X,Mas JL,et al.Mechanical thrombectomyafter intravenous alteplase versus alteplase alone after stroke(THRACE):a randomised controlled trial[J].Lancet Neurol,2016,15( 11):1138~1147. [3] Lalbers GW,Lansberg MG,Kemp S,et al.A multicenterrandomized controlled trial of endovascular therapy followingimaging evaluation for ischemic stroke (DEFUSE 3)[J].Int Stroke,2017,12(8):896~905. [4] Nogueira RG,Jadhav AP,Haussen DC,et al.Thrombectomy6 to 24 hours after stroke with a mismatch between deficitand infarct[J].N Engl Med,2017,378(1):11~21. [5] 冯锦丽,王卫.急性脑梗死患者循环 miR-124表达水平与脑梗死体积、神经功能缺损程度的关系及其诊断价值[J].卒中与神经疾病,2018,25 ( 1 ):21~24,38. [6] Prabhakaran S,Ruff I,Bernstein RA.Acute stroke intervention:a systematic review[J].JAMA,2015,313(14):1451~1462. [7] Haller S,Zaharchuk G,Thomas DL,et al.Arterialspin labeling perfusion of the brain:emerging clinical applications[J].Radiology,2016,281(2):337~356. [8] 李世星,刘子航,张凯旋,等.联合3D-ASL和DWI评价静脉溶栓治疗早期急性脑梗死疗效的价值[J].中国现代医生,2020,58(3):133~1366,139. |